Loading...
SeniorFull-timeCI/CDAI
Salary Range
$132,600 - $179,400 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
We are looking for a Software Quality Engineer who is passionate about engineering teams owning quality. In this role, you'll work directly with product engineering squads to embed quality into how they design, build, test, and ship software.
Key Responsibilities
- →Lead testing efforts and best practices for your feature areas, pushing ownership of unit, component, and service-level tests into engineering teams while you focus on high-risk end-to-end automation.
- →Evolve, maintain automation and integrate these into CI/CD so every change gets fast, reliable quality feedback.
- →Enable engineers with quality-focused test design, and shift-left practices through pairing, reviews, and hands-on workshops.
- →Translate business and technical risks into clear test strategies, acceptance criteria, and living documentation that teams own and maintain.
- →Define and refine quality standards, policies, and risk-based testing guidelines that align with product and compliance needs.
- →Use metrics such as defect trends, coverage, and flakiness to highlight systemic issues and drive continuous improvement across teams.
- →Collaborate with engineering and product leadership to communicate quality posture, surface risks, and support informed tradeoffs without acting as a release bottleneck.
- →Mentor junior QA and engineers on modern testing techniques, observability-driven validation, and emerging practices like AI-assisted and autonomous testing.
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
